UCHID2021

Revive the whole experience NOW

DAY 2

Friday 6 November 2020

Liverpool Meeting

Key drug interaction issues from EASL Guidelines 2020

Fiona Marra

Role of the pharmacist in DAA prescribing and HCV elimination.

Alison Boyle

Managing HIV/HCV/TB coinfection: the hard way for cure.

Ahmed Cordie

IBD School

IBD school

Ismail Anwar

Ain shams IBD MDT success story

Ayat Abdallah

Insurance experience in IBD MDT

Fathia Hamed

Bowel ultrasound Case Presentation

Yasmin Gaber

Breakthrough in biological therapy

Mohamed El Tabbakh

Cairo University IBD MDT success story

Hedy Ayman

Bowel ultrasound: An emerging tool in diagnosis and follow up of IBD patients

Shaimaa Youssef

COVID Recap

Covid Summary
Mohamed El Badry

Role of lung ultrasound during COVID-19 pandemic
Samy Zaky

Mansoura -NZIR study for treatment of COVID-19: a single-center experience
Mahmoud El Bendary

.

Plenary Session III

Hepatorenal syndrome

Imam Waked

Fungal dysbiosis and gastrointestinal disorders

Maysaa Abdallah

Future therapies for HBV cure
Marc Bourliere

Dual release proton pump inhibitors; are they different?
Ahmed Zaid

Interactive Sessions

Annoying problems in cirrhotic patients (intractable itching, muscle cramps)

Hypersplenism and its sequelae: multidisciplinary approach

HCC in Liver transplantation, what’s beyond the Milan criteria

Chronic fatigue syndrome: a truth or myth and how to approach?

Travel medicine

Unexplained prolonged fever: Algorithmic approach

Industrial Spot

Sanofi

Plenary Session IV

Neuro endocrinal tumors: Case presentation

Sherif Megawer

Effect of bariatric surgery on GERD

Mohamed Magdy

Communicable diseases: pre- and post-exposure prophylaxis.
Fatma Ali El Din

Cirrhotic Cardiomaypathy
Sam Lee